Download full-text PDF

Source

Publication Analysis

Top Keywords

verapamil stroke
4
stroke volume
4
volume supraventricular
4
supraventricular arrhythmias
4
verapamil
1
volume
1
supraventricular
1
arrhythmias
1

Similar Publications

Background: Direct oral anticoagulants (DOACs) are preferred for stroke prevention in nonvalvular atrial fibrillation (NVAF); however, warfarin is still used. This study examined why physicians may choose warfarin over DOACs and the associated safety outcomes in patients with NVAF.

Methods: We conducted a new-user, active-comparator cohort study in newly diagnosed patients with NVAF to assess safety outcomes after the introduction of DOACs in Japan.

View Article and Find Full Text PDF

Migrainous infarction is a rare complication of migraine that mostly occurs in the posterior circulation and in younger women, with an incidence of less than 1%. It is known that migraine, especially migraine with aura, is a risk factor for ischemic stroke in younger adults but not in the elderly. We report a 71-year-old male patient who experienced abnormal visions due to migraine headache and persistent aura, causing bilateral occipital infarcts.

View Article and Find Full Text PDF

Background: Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by diffuse, multifocal segmental narrowing of cerebral arteries and can result in ischaemic stroke. Causal factors, identified in 60% of cases, include immunosuppressant pharmacotherapy. The few reports following heart transplantation are almost all in Asian recipients.

View Article and Find Full Text PDF

The erythrocyte S1P transporter Mfsd2b is also expressed in the heart. We hypothesized that S1P transport by Mfsd2b is involved in cardiac function. Hypertension-induced cardiac remodeling was induced by 4-weeks Angiotensin II (AngII) administration and assessed by echocardiography.

View Article and Find Full Text PDF

Background: Direct oral anticoagulants (DOACs) are commonly co-prescribed with amiodarone/diltiazem/verapamil, but whether there is a drug interaction between these drugs is unclear.

Objective: The purpose of this study was to investigate the risk of clinical outcomes associated with concomitant use of DOACs and amiodarone/diltiazem/verapamil.

Methods: We identified DOAC users in the Clinical Practice Research Datalink Aurum from January 1, 2011, to December 31, 2019.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!